Global ePrescribing Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2018 Update)
- 150 Pages
- Region: Global
The global eprescribing market is expected to grow from USD 548.30 million 2016 to USD 2,532.56 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 21.08%.
“Improving patient safety and reduce prescription errorsis one of the factors largely attributing to the growth of eprescribing market globally”
The factors attributing to the growth of the market are improving patient safety and reduce prescription errors, increasing patient convenience and medication compliance, and drug abuse prevention and improved drug surveillance. However, some factors such as implementation cost and roi, and technical complexity and data availability may hinder the market growth. The global eprescribing market is expected to showcase the opportunities such as integrating e-prescription software, and hipaa compliance. In the near future, the market may face the possible challenges in the growth due to reluctance towards the adoption of technology, and security issues. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global eprescribing market market.“Integrated: The highest growing product for the global eprescribing market”
On the basis of product, the global eprescribing market is studied across Integrated and Standalone. Among all these product, the Integrated is projected to hold the largest market share while the Integrated has the potential to grow the market with the highest CAGR in the forecast period.“On-Cloud: The highest growing deployment for the global eprescribing market”
On the basis of deployment, the global eprescribing market is studied across On-Cloud and On-Premises. Among all these deployment, the On-Cloud has captured the maximum market share while the On-Cloud has the opportunity to emerge with the highest CAGR.“Infectious Diseases: The highest growing end user for the global eprescribing market”
On the basis of end user, the global eprescribing market is studied across Infectious Diseases, Pharmacies, and Physicians. Among all these end user, the Infectious Diseases has captured the maximum market share while the Physicians has the opportunity to emerge with the highest CAGR.“Americas: The highest growing geography for the global eprescribing market”
On the basis of geography, the global eprescribing market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia). Among all these geography, the Asia-Pacific is showing the maximum growth in the near future with the highest CAGR while the Americas is dominating the market with highest market size.
“AdvancedMD, Inc.: The potential growing player for the global eprescribing market”
The key players profiled in the global eprescribing market are AdvancedMD, Inc., Allscripts Healthcare Solutions, Inc., Bizmatics, Inc., CareCloud Corporation, Computer Programs and Systems, Inc., DrFirst, Inc., MDToolbox, McKesson Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., Relayhealth Corporation, Surescripts LLC, and athenahealth, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global eprescribing market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global eprescribing market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global eprescribing market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global eprescribing market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global eprescribing market.